Concepedia

Azura Rozila Ahmad

AR

Statistics

Publications

2

Citations

298

H-Index

2

Active since

2020

Affiliations

Seoul National University Hospital(Current)

Guangdong Provincial People's Hospital

Shanghai Chest Hospital

National Taiwan University Hospital

Zhejiang Cancer Hospital

Azura Rozila Ahmad is an author at Seoul National University Hospital specializing in medicine, met-targeted therapy, and amplification.

ORCID

Publications per year

2020–2023

2

Publications

2

Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

Yi‐Long Wu, Ying Cheng, Jianying Zhou et al. · The Lancet Respiratory Medicine · 2020 · 258 citations

, , +17

Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in <i>EGFR</i> -Mutant NSCLC with EGFR Inhibitor Resistance Due to <i>MET</i> Amplification: INSIGHT Final Analysis

Chong Kin Liam, Azura Rozila Ahmad, Te‐Chun Hsia et al. · Clinical Cancer Research · 2023 · 40 citations · Full text

, , +17

1–2 of 2